Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of “Buy” from Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been given an average rating of “Buy” by the sixteen research firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $25.07.

PRVA has been the subject of a number of recent analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research note on Wednesday, August 14th. Robert W. Baird upped their price target on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, August 26th. KeyCorp initiated coverage on Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 price target for the company. Barclays upped their price target on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. Finally, Truist Financial upped their price target on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th.

Privia Health Group Trading Down 1.2 %

Privia Health Group stock opened at $20.95 on Tuesday. The company has a market cap of $2.51 billion, a PE ratio of 209.52, a PEG ratio of 5.29 and a beta of 0.76. The company’s 50-day moving average is $18.76 and its two-hundred day moving average is $18.51. Privia Health Group has a 1 year low of $15.92 and a 1 year high of $24.30.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the transaction, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This trade represents a 35.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 14.20% of the company’s stock.

Hedge Funds Weigh In On Privia Health Group

Hedge funds have recently made changes to their positions in the business. Canada Pension Plan Investment Board acquired a new stake in shares of Privia Health Group in the 2nd quarter valued at approximately $26,000. Nisa Investment Advisors LLC boosted its holdings in shares of Privia Health Group by 107.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after buying an additional 930 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after buying an additional 845 shares during the last quarter. Signaturefd LLC boosted its holdings in shares of Privia Health Group by 46.3% in the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after buying an additional 626 shares during the last quarter. Finally, Quarry LP boosted its holdings in shares of Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after buying an additional 2,533 shares during the last quarter. 94.48% of the stock is owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.